Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
NCT01854060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 440822
Last updated 2013-05-15
Summary
The prevalence of IBS in the community has been reported in numerous cross-sectional surveys. However, less is known about the incidence of IBS ,mainly due to its slow development and to patients under-reporting. Furthermore, only one study has analyzed data concerning potential risk factors for the diagnosis of IBS. The investigators will examine the incidence of IBS in a large cohort of young adults and will look at the association of socioeconomic, anthropometric and occupational factors with IBS incidence.
Conditions
- Irritable Bowel Syndrome
Sponsors & Collaborators
-
Medical Corps, Israel Defense Force
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 39 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
Countries
- Israel
Study Locations
More Related Trials
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Irritable Bowel Syndrome in Medical Students Africa
NCT06097598 ·Status: NOT_YET_RECRUITING
-
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903 ·Status: COMPLETED
-
Irritable Bowel Syndrome Overlaping Celiac Disease
NCT05740306 ·Status: UNKNOWN
-
A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
NCT00189813 ·Status: COMPLETED ·Phase: PHASE2
-
An Assessment of Cognitive Function in Irritable Bowel Syndrome
NCT01304355 ·Status: UNKNOWN
-
Irritable Bowel Syndrome Hypnotherapy
NCT01248013 ·Status: COMPLETED ·Phase: NA
-
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 ·Status: UNKNOWN ·Phase: PHASE4
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome
NCT02545413 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Intracolonic FODMAP Infusion in Healthy Volunteers
NCT06488534 ·Status: COMPLETED ·Phase: NA
-
Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome
NCT01632488 ·Status: UNKNOWN
-
Tolerability and Effectiveness of Progut in Treatment of Irritable Bowel Syndrome
NCT00904696 ·Status: COMPLETED
-
Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)
NCT00130741 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01923428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Immunological Change and the Single Nucleotide Polymorphism (SNP) in Children With Irritable Bowel Syndrome (IBS)
NCT01131442 ·Status: UNKNOWN
-
Exercise and Irritable Bowel Syndrome (IBS)
NCT05453084 ·Status: COMPLETED ·Phase: NA
-
Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel
NCT00742118 ·Status: UNKNOWN ·Phase: NA
-
Probiotics in Irritable Bowel Syndrome
NCT00846170 ·Status: WITHDRAWN ·Phase: PHASE3
-
Gastrointestinal Symptoms in Healthy Subjects and Patients With Irritable Bowel Syndrome
NCT01457378 ·Status: COMPLETED
-
Integrative Approaches to Managing Irritable Bowel Syndrome (IBS)
NCT02436603 ·Status: COMPLETED ·Phase: NA
-
Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy
NCT01413945 ·Status: TERMINATED
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2